At the same time, we are facing an exciting multifaceted future, with several novel developments on the horizon with the potential to change the clinic setting, including the development of oral GLP-1 receptor agonists and the emerging formulations of GIP receptor agonists and dual and triple receptor agonists, which have shown clear therapeutic potential
The 12.5 to 15 mg band adds modestly to average weight loss but widens the high-response tail
Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 induces G-protein-coupled receptor heteromer formation
In the real-world comparative effectiveness study, tirzepatide proved more effective for weight loss within a year of treatment
"These sites get shut down daily who knows what they are actually dispensing." Legitimate compound companies only work with physicians, Decotiis said, and do not communicate directly with patients
Answer questions you have about anesthesia